Antisauvagine-30 TFA (aSvg-30 TFA) is a potent, highly selective and competitive CRF2 receptor peptidic antagonist. Antisauvagine-30 TFA exhibits a Kd of 1.4 nM and 150 nM for mCRFR2β and CRFR1, respectively.
体外研究
Antisauvagine-30 (aSvg-30) prevents stress-enhanced fear conditioning and Mek-1/2-dependent activation of Erk-1/2 and p90Rsk-1. Antisauvagine-30 (aSvg-30) did not affect the phosphorylation of the PKA regulatory subunit II of stressed mice.
体内研究
Antisauvagine-30 (aSvg-30; i.h. 400 ng/0.5 μl per mouse) selectively prevents the stress-induced enhancement of fear conditioning without affecting the fear conditioning of nonstressed mice.
Antisauvagine-30 (aSvg-30) injected i.c.v. elicits a significant anxiogenic effect.
Animal Model:
Nine-week-old male BALB/c mice.
Dosage:
400 ng/0.5 μl per mouse.
Administration:
Administered bilaterally by a microinjector (intrahippocampal (i.h.) injection).
Result:
Prevented the stress-induced enhancement of fear conditioning.
运输条件
Room temperature in continental US; may vary elsewhere.